Genomic and Transcriptomic Characterization of Protein Kinase C Fusion Melanocytic Neoplasms With Distinctive Hypopigmented Histomorphology: A Single‐Institution Study
Journal of Cutaneous Pathology · 2025
DOI: 10.1111/cup.14801 ↗At a glance
Journal article in Journal of Cutaneous Pathology, 2025. Written by Aofei Li and 6 co-authors. Institution: Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. Major MEDLINE topics: Skin Neoplasms, Transcriptome, Melanoma, Protein Kinase C. Cited 7 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Genomic fusions involving Protein Kinase C ( PKC or PRKC ) have been classically identified in a subset of melanocytic neoplasms with heavy melanin pigmentation as described in older series. They were recently reclassified from the pigmented epithelioid melanocytoma (PEM) category to the blue nevus (BN) category in the fifth edition of the World Health Organization (WHO) Classification of Skin Tumors.
Methods
Herein, we report a series of eight mostly hypopigmented PRKC fusion melanocytic tumors with novel comprehensive molecular characterization. Clinical, histopathologic, and immunohistochemical findings were reviewed. Next‐generation sequencing (NGS) data on genomic and transcriptomic levels were explored.
Results
Histomorphology showed a biphasic pattern with hypercellular areas and hypocellular areas with dense fibrotic stroma and collagen trapping. The clinical courses were uncomplicated after excisions. NGS revealed three cases of PRKCB fusion and five cases of PRKCA fusions. RNA differential analysis against six blue nevi showed a group of genes with significantly higher transcription levels and strong enrichment in the direct p53 effectors gene set. PRKC fusion tumors also demonstrated significantly stronger p53 IHC staining.
Conclusion
We further expand the morphologic spectrum of PRKC fusion melanocytic tumors and provide insight into their morphologic identification. Our novel transcriptome‐level findings provide insight into the nuanced molecular events and new evidence for classification.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Tempus Labs Inc., Chicago, Illinois, USA.
- Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
ORCID profiles: Aofei Li, Ryan Jones, Ahmed K Alomari
Cite
APA
Li, A., Umphress, B., Dehner, C., Jones, R., Toral, K., Warren, S., & Alomari, A. K. (2025). Genomic and Transcriptomic Characterization of Protein Kinase C Fusion Melanocytic Neoplasms With Distinctive Hypopigmented Histomorphology: A Single‐Institution Study. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14801
Vancouver
Li A, Umphress B, Dehner C, Jones R, Toral K, Warren S, et al. Genomic and Transcriptomic Characterization of Protein Kinase C Fusion Melanocytic Neoplasms With Distinctive Hypopigmented Histomorphology: A Single‐Institution Study. Journal of Cutaneous Pathology. 2025. doi:10.1111/cup.14801
BibTeX
@article{Li2025,
author = {Li, Aofei and Umphress, Brandon and Dehner, Carina and Jones, Ryan and Toral, Keller and Warren, Simon and Alomari, Ahmed K},
title = {Genomic and Transcriptomic Characterization of Protein Kinase C Fusion Melanocytic Neoplasms With Distinctive Hypopigmented Histomorphology: A Single‐Institution Study},
journal = {Journal of Cutaneous Pathology},
year = {2025},
doi = {10.1111/cup.14801}
}
EUVIMED